Trial Profile
A Preliminary Study of Prophylactic Fentanyl Buccal Tablets (FBT) for Exercise Induced Breakthrough Dyspnea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2020
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Dyspnoea
- Focus Therapeutic Use
- 29 Jan 2020 Planned initiation date changed from 1 May 2014 to 27 May 2014.
- 29 Jan 2020 Status changed from active, no longer recruiting to completed.
- 02 Jun 2017 Results analysing the effect of prophylactic fentanyl buccal tablet (FBT) on exertional dyspnea in patients with cancer, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.